Clinical Trials Logo

Plaque, Dental clinical trials

View clinical trials related to Plaque, Dental.

Filter by:

NCT ID: NCT04137393 Completed - Plaque, Dental Clinical Trials

The Effect of Brushing With Salvadorapersica (Miswak) Sticks on Salivary Streptococcus Mutants and Plaque Level in Children: A Clinical Trial

Start date: October 2016
Phase: Phase 3
Study type: Interventional

Objectives: to evaluate the effect of brushing with Salvadora persica (Miswak) on streptococcus mutants compared to brushing with fluoridated tooth paste (FTP) in children. Methods: A total of 94 healthy children (8 years old) from an elementary governmental school in Jeddah, Saudi Arabia were grouped to Miswak and FTP groups. They were assessed for their salivary level of mutans streptococci species, and lactobacillus at the baseline and three weeks after brushing. Caries level using DMFT/dmft, and plaque amount using Greene Vermillion simplified oral hygiene index were recorded.

NCT ID: NCT04003493 Completed - Oral Mucositis Clinical Trials

LifE Style, Nutrition and Oral Health in Care Givers (LENTO)

Start date: May 15, 2019
Phase: N/A
Study type: Interventional

The LENTO study sample includes the caregivers and their clients living in eastern Finland. The aims of this study are 1. to study the nutritional status, oral health, coping, functional capacity and quality of life 2. to find out how individual nutrition and oral health counseling received for caregivers affect on the nutritional status and oral health of caregivers and their clients 3. develop an operating model to maintain good nutrition and oral health.

NCT ID: NCT03219840 Completed - Clinical trials for Periodontal Diseases

Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis

Start date: October 18, 2017
Phase: Phase 4
Study type: Interventional

This placebo-controlled, double-blinded, randomized crossover study evaluates the plaque and gingivitis reducing capacity of Cetylpyridium Chloride (CPC) chewing gum, with mechanical oral hygiene. The study will enroll 73 students, faculty, and staff from the UTHealth School of Dentistry. Half of the eligible participants will be randomly assigned to get the CPC gum in the first treatment period (21 days), a wash-out period of 21 days, and then a placebo gum in the second treatment period (21 days). The other half will be assigned to follow the same schedule but with the treatment reversed. A statistician will perform the randomization. Primary outcomes are assessed by validated tools, such as the Plaque Index (PI), Gingival Index (GI), and percent of bleeding sites on probe (BOP).